Document Detail


Effect of short-term free Fatty acids elevation on mitochondrial function in skeletal muscle of healthy individuals.
MedLine Citation:
PMID:  19864449     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: Mitochondrial dysfunction has been proposed as an underlying mechanism in the pathogenesis of insulin resistance and type 2 diabetes mellitus.
OBJECTIVE: To determine whether mitochondrial dysfunction plays a role in the free fatty acid (FFA)-induced impairment in insulin action in skeletal muscle of healthy subjects.
DESIGN: Eleven lean normal glucose tolerant individuals received 8 h lipid and saline infusion on separate days with a euglycemic insulin clamp during the last 2 h. Vastus lateralis muscle biopsies were performed at baseline and after 6 h lipid or saline infusion. Inner mitochondrial membrane potential (Psi(m)) and mitochondrial mass were determined ex vivo by confocal microscopy.
RESULTS: Compared with saline infusion, lipid infusion reduced whole-body glucose uptake by 22% (P < 0.05). Psi(m) decreased by 33% (P < 0.005) after lipid infusion and the decrement in Psi(m) correlated with change in plasma FFA after lipid infusion (r = 0.753; P < 0.005). Mitochondrial content and morphology did not change after lipid infusion. No significant changes in genes expression, citrate synthase activity, and total ATP content were observed after either lipid or saline infusion.
CONCLUSIONS: Short-term physiological increase in plasma FFA concentration in lean normal glucose tolerant subjects induces insulin resistance and impairs mitochondrial membrane potential but has no significant effects on mitochondrial content, gene expression, ATP content, or citrate synthase activity.
Authors:
Alberto O Chavez; Subhash Kamath; Rucha Jani; Lokendra K Sharma; Adriana Monroy; Muhammad A Abdul-Ghani; Victoria E Centonze; Padma Sathyanarayana; Dawn K Coletta; Cristopher P Jenkinson; Yidong Bai; Franco Folli; Ralph A Defronzo; Devjit Tripathy
Related Documents :
7905709 - Impact of variable insulinemia and glycemia on in vivo glycolysis and glucose storage i...
8476039 - Contribution of muscle and liver to glucose-fatty acid cycle in humans.
9593779 - Insulin therapy in burn patients does not contribute to hepatic triglyceride production.
16054069 - The ffa receptor gpr40 links hyperinsulinemia, hepatic steatosis, and impaired glucose ...
574299 - Diurnal profiles of serum insulin, c-peptide and blood intermediary metabolites in insu...
9012639 - Differences in insulin suppression of free fatty acid levels by gender and glucose tole...
22258539 - Physical activity in the prevention of chronic kidney disease.
16303639 - Soluble cd40 ligand levels in patients with hypertension.
22083509 - Beneficial effect of myricetin on renal functions in streptozotocin-induced diabetes.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2009-10-28
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  95     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-08     Completed Date:  2010-02-01     Revised Date:  2011-07-19    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  422-9     Citation Subset:  AIM; IM    
Affiliation:
Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, Texas 78229, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / metabolism
Adult
Citrate (si)-Synthase / metabolism
Fatty Acids, Nonesterified / administration & dosage,  blood*,  pharmacology*
Female
Glucose / metabolism
Glucose Clamp Technique
Health
Humans
Infusions, Intravenous
Insulin / blood,  metabolism
Lipids / administration & dosage,  pharmacology
Male
Membrane Potential, Mitochondrial / drug effects
Mitochondria, Muscle / drug effects*,  genetics,  metabolism,  physiology
Muscle, Skeletal / drug effects*,  physiology
Up-Regulation / physiology
Grant Support
ID/Acronym/Agency:
DK-24092/DK/NIDDK NIH HHS; P01AG19316/AG/NIA NIH HHS; P30 AG013319/AG/NIA NIH HHS; P30 CA54174/CA/NCI NIH HHS; R01 DK079195-03/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Fatty Acids, Nonesterified; 0/Lipids; 11061-68-0/Insulin; 50-99-7/Glucose; 56-65-5/Adenosine Triphosphate; EC 2.3.3.1/Citrate (si)-Synthase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancy.
Next Document:  Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG s...